InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: EYEBUYSTOX post# 178004

Thursday, 05/29/2014 7:55:26 PM

Thursday, May 29, 2014 7:55:26 PM

Post# of 346050
That Nexavar/Bavi trial is only being conducted at UTSWM also... so safe to say no mix ups of any kind will be going on there.

The current trial of Bavi + Sorafenib is a single institution trial University of Texas at Southwestern Medical and if results top those of Sorafenib alone...

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=89605535&txt2find=bayer|nexafar


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News